Breast cancer specialist Hal Burstein, MD, PhD from the Susan F. Smith Center for Women's Cancers at Dana-Farber Cancer Institute, explains the difference between tamoxifen and aromatase inhibitors, and when each are used when treating breast cancer. Learn more about Dana-Farber’s breast oncology program at: [ Ссылка ]

свернуть